Clinica
Lombard to raise £27.5m in push for Aorfix US approval "early next year"
21 April 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Medtronic maintains leadership in EVAR market with CE mark of next-gen Endurant stent
- Potential US Aorfix approval delay; Lombard's extra £3m to act as buffer
- LeMaitre exits peripheral vascular stent business; ends distribution agreement with Endologix
- Positive data backs Medtronic's Valiant thoracic stent graft for treating degenerative TAA
Other Informa News
EVENTS
